Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T09:40:35.784Z Has data issue: false hasContentIssue false

33 - Uterine Sarcoma

from Section 5 - Gynecologic Oncology

Published online by Cambridge University Press:  01 February 2018

By
Caroline C. Billingsley  and
Eric L. Eisenhauer
Edited by
Lisa Keder  and
Martin E. Olsen
Lisa Keder
Affiliation:
Ohio State University
Martin E. Olsen
Affiliation:
East Tennessee State University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Gynecologic Care , pp. 317 - 328
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tropé, C.G., Abeler, V.M., Kristensen, G.B.. Diagnosis and treatment of sarcoma of the uterus: a review. Acta Oncol 2012; 51(6):694–705.CrossRefGoogle ScholarPubMed
Abeler, V.M, Royne, O., Thoresen, S.O. et al. Uterine sarcomas in Norway: a histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009; 54:355–64.CrossRefGoogle ScholarPubMed
Tavassoli, F.A., Devilee, P., editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press;2003.Google Scholar
Kurman, R.J., Carcangiu, M.L., Herrington, C.S. et al. WHO Classification of Tumors of the Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014;307.Google Scholar
D’Angelo, E., Prat, J.. Uterine sarcomas: a review. Gynecol Oncol 2010; 116(1):131–6.Google ScholarPubMed
Otis, C., Ocampo, A.. Protocol for the examination of specimens from patients with sarcoma of the uterus, 2013. College of American Pathologists. www.cap.org/apps/docs/committees/cancer/cancer_protocols/2013/UterineSarcomaProtocol_3000.pdf (Accessed on April 29, 2014).Google Scholar
Helman, L.J., Meltzer, P.. Mechanisms of sarcoma development. Nat Rev Cancer 2003; 3:685–94.Google Scholar
Conklin, C.M., Longacre, T.A.. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014; 21(6):383–93.CrossRefGoogle ScholarPubMed
Nordal, R.R., Thoresen, S.O.. Uterine sarcomas in Norway 1956–1992: incidence, survival and mortality. Eur J Cancer 1997; 33:907–11.Google Scholar
Montague, A.C., Swartz, D.P., Woodruff, J.D.. Sarcoma arising in a leiomyoma of the uterus: factors influencing prognosis. Am J Obstet Gynecol 1965; 92:421–7.CrossRefGoogle Scholar
Parker, W.H., Fu, Y.S., Berek, J.S.. Uterine sarcoma in patienrs operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994; 83:414–18.Google Scholar
Rha, S.E.,Byun, J.Y., Jung, S.E. et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003; 181:1369–74.Google Scholar
Kitajima, K., Murakami, K., Kaji, Y. et al. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol 2010; 195:737–43.Google Scholar
Menczer, J., Schreiber, L., Berger, E. et al. CA125 Expression in the tissue of uterine leiomyosracoma. Isr Med Assoc J 2014; 16(11):697–9.Google Scholar
Goto, A., Takeuchi, S., Sugimura, K. et al. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002; 12(4):354–61.Google Scholar
Bansal, N., Herzog, T.J., Burke, W. et al. The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol 2008;110(1):43–8.Google Scholar
National Comprehensive Cancer Network (NCCN) Guidelines. Uterine sarcoma, Version 2.2016, (Accessed February 22, 2016).Google Scholar
Zaloudek, C.J., Morris, H.J.. Mesenchymal tumors of the uterus. In: Fenoglio, CM, Wolff, M, editors. Progress in Surgical Pathology. Vol. 3. New York: Masson-Publishing Inc.;1981; 1–35.Google Scholar
Giuntoli, R.L., Metzinger, D.S., DiMarco, C.S. et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003; 89(3):460–9.Google Scholar
Dinh, T.A., Oliva, E.A., Fuller, A.F. Jr et al. The treatment of uterine leiomyosarcoma: results from a 10-year experience (1990–1999) at the Massachusetts General Hospital. Gynecol Oncol 2004; 92(2):648–52.Google Scholar
Leitao, M.M., Sonoda, Y., Bristow, R.R. et al. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 2003; 91(1):209–12.CrossRefGoogle ScholarPubMed
Hensley, M.L., Barrette, B.A., Baumann, K. et al. Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas. J Gynecol Cancer 2014; 24(9 Suppl 3):S61–6.Google Scholar
Kelley, T.W., Borden, E.C., Goldblum, J.R.. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Appl Immunohistochem Mol Morphol 2004; 12(4):338–41.Google Scholar
Kapp, D.S., Shin, J.Y., Chan, J.K.. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008; 112(4):820–30.Google Scholar
Major, F.J. FJ, Blessing, J.A., Silverberg, S. G. et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer 1993; 71:1702–9.Google Scholar
Omura, G.A., Blessing, J.A., Major, F. et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3(9):1240–5.Google Scholar
Reed, N.S., Mangioni, C., Malmström, H et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008; 44(6):808–18.Google Scholar
Hensley, M.L., Wathen, J.K, Maki, R.G. et al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Cancer 2013; 119(8):1555–61.Google Scholar
Hensley, M.L., Blessing, J.A., Mannel, R. et al. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 2008; 109(3):329–34.Google Scholar
Hensley, M.L., Ishill, N., Soslow, R. et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol 2009; 112(3):563–7.Google Scholar
Moskovic, E., MacSweeney, E., Law, M. et al. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol 1993; 66(791):1009–15.Google Scholar
Maki, R.G., Wathen, J.K., Patel, S.R. et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol 2007; 25(19):2755–63.Google Scholar
Hensley, M.L., Blessing, J.A., Degeest, K. et al. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol 2008; 109(3):323–8.Google Scholar
Hensley, M.L., Miller, A., O’Malley, D.M. et al. A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): a Gynecologic Oncology Group study. Gynecol Oncol 2014; 133:3(SGO #2)(Abstract).Google Scholar
Sanfilippo, R., Grosso, F., Jones, R.L. et al. Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers. Gynecol Oncol 2011; 123(3):553–6.CrossRefGoogle ScholarPubMed
van der Graaf, W.T., Blay, J.Y., Chawla, S.P. et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012; 379(9829):1879–86.Google Scholar
O’Cearbhaill, R., Zhou, Q., Iasonos, A. et al. Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors. Gynecol Oncol 2010; 116(3):424–9.Google Scholar
Bell, S.W., Kempson, R.L., Hendrisckson, M.R.. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994; 18(6):535–58.Google Scholar
Chan, J.K., Kawar, N/M., Shin, J.Y. et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 2008; 99(8):1210–5.Google Scholar
Baker, P., Oliva, E.. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol 2007; 60(3):235–43.Google Scholar
Dionigi, A., Oliva, E., Clement, P.B. et al. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 2002; 26(5):567–81.Google Scholar
Tavassoli, F.A., Norris, H.J. Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules. Histopathology 1981; 5(1):1–10.Google Scholar
Reich, O., Regauer, S., Urdl, W. et al. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000; 82(5):1030–4.Google Scholar
Nucci, M.R., Harburger, D., Koontz, J. et al. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 2007; 31(1):65–70.Google Scholar
Gadducci, A., Cosio, S., Romanini, A. et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 2008; 65(2):129–42.Google Scholar
Shah, J.P., Bryant, C.S., Kumar, S. et al. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 2008; 112(5):1102–8.CrossRefGoogle ScholarPubMed
Li, N., Wu, L.Y., Zhang, H.T et al. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 2008; 108(2):306–11.Google Scholar
Chang, K.L, Crabtree, G.S, Lim-Tan, S.K. et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990; 14(5):415–38.CrossRefGoogle ScholarPubMed
Pink, D., Lindner, T., Mrozek, A. et al. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 2006; 101(3):464–9.Google Scholar
Reich, O., Rehauer, S.. Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 2007; 19(4):347–52.Google Scholar
Chew, I., Oliva, E.. Endometrial stromal sarcomas: a review of potential prognostic factors. Adv Anat Pathol 2010; 17(2):113–21.Google Scholar
Beck, T.L., Singhal, P.K., Ehrenberg, H.M et al. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment. Gynecol Oncol 2012; 125(1):141–4.CrossRefGoogle ScholarPubMed
Lee, C.H., Marino-Enriquez, A., Ou, W. et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 2012; 36(5):641–53.Google Scholar
Amant, F., Coosemans, A., Debiec-Rychter, M. et al. Clinical management of uterine sarcomas. Lancet Oncol 2009; 10(12):1188–98.Google Scholar
Tanner, E.J., Garg, K., Soslow, M.M., Jr et al. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 2012; 127(1):27–31.Google Scholar
Leath, C.A., Huh, W.K., Hyde, J., Jr et al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007; 105(3):630–4.CrossRefGoogle ScholarPubMed
Greer, B.E., Koh, W.J., Abu-Rustum, N. et al. Uterine neoplasms: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009; 7(5):498–531.Google Scholar
Malouf, G.G., Lhomme, C., Duvillard, P. et al. Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy. Int J Gynaecol Obstet 2013;122(1):57–61.Google Scholar
Clement, P.B., Scully, R.E.. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990; 21(4):363–81.CrossRefGoogle ScholarPubMed
P.B. Clement, . Mullerian adenosarcoma of the uterus wuth sarcomatous overgrowth: a clinicopathological analysis of 10 cases. Am J Surg Pathol 1989; 13(1):28–38.Google Scholar
Gallardo, A., Prat, J.. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 2009; 33(2):278–88.Google Scholar
Nam, J.H.. Surgical treatment of uterine sarcoma. Best Pract Res Clin Obstet Gynaecol 2011; 25(6):751–60.Google Scholar
Tanner, E.J., Toussaint, T., Leitao, M.M. et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol 2013; 129(1):140–4.Google Scholar
Krivak, T.C., Seidman, J.D., McBroom, J.W. et al. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 2001; 83(1):89–94.Google Scholar
Friendlander, M.L., Covens, A., Glasspool, R.M. et al. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 2014; 24(9 Suppl 3):S78–82.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×